Skip to main content
Medicure Inc logo

Medicure Inc — Investor Relations & Filings

Ticker · MPH ISIN · CA58469E4085 LEI · 9845007T999BF377B627 TSXV Manufacturing
Open in API
Filings indexed 291 across all filing types
Latest filing 2025-04-23 Earnings Release
Country CA Canada
Listing TSXV MPH

About Medicure Inc

https://www.medicure.com/

Medicure Inc. is a value-based pharmaceutical company specializing in the research, clinical development, and commercialization of human therapeutics. The company is primarily focused on developing and commercializing innovative and affordable medicines within the cardiovascular therapeutic area. Medicure's core mission is to serve patients by delivering safe and efficacious life-changing medicines, with a strategic focus on the U.S. market. It aims to offer a growing portfolio of products and services, ensuring patient access to necessary care.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Earnings Release Classification · 85% confidence The document is a press release announcing an upcoming conference call to present the company’s quarterly and year-end financial results. It does not contain the full report or transcript but is clearly related to earnings communication. This matches the “Earnings Release (ER)” category, which covers initial announcements of periodic financial results. FY 2024
2025-04-23 English
News release - English.pdf
M&A Activity Classification · 95% confidence The document is a corporate press release announcing the signing of a definitive agreement to acquire another company (West Olympia Pharmacy). It details the purchase price, transaction conditions, and strategic rationale, which clearly falls under M&A activity. Therefore, it should be classified as M&A Activity (Code: TAR).
2025-04-11 English
News release - English.pdf
Regulatory Filings
2025-03-12 English
Notice of the meeting and record date - English.pdf
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a formal notice from the transfer agent (Computershare) to Canadian securities regulators detailing the upcoming Annual Meeting of Security Holders, record dates, voting details, and Notice and Access requirements – all components of the proxy solicitation process. It is not the full proxy statement itself but clearly relates to soliciting votes and providing meeting information. This aligns with the definition of a Proxy Solicitation & Information Statement (PSI).
2025-03-10 English
News release - English.pdf
M&A Activity Classification · 92% confidence The document is a corporate press release announcing that Medicure has signed a definitive agreement to acquire Gateway Medical Pharmacy. It outlines the transaction details, strategic rationale, and closing conditions. This is clearly an M&A transaction announcement (acquisition), fitting the M&A Activity category.
2025-02-18 English
News release - English.pdf
Regulatory Filings
2024-11-26 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.